Square Pharmaceuticals PLC. — Company profile

Pharmaceutical Preparations · Bangladesh

Last price 218.5 BDT (At close: Oct 29, 2026) · Market cap 193.69B

Latest research: Square Pharmaceuticals valuation report: fair value BDT 218–397 (Oct 2026) · Square Pharmaceuticals: fair value BDT 218–397, base 316; cash and investments are BDT 112 a share

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Technical report: trend, RSI, support and resistance, charts

Company profile

Square Pharmaceuticals PLC., together with its subsidiaries, manufactures, markets, and distributes pharmaceutical products in Bangladesh and internationally. The company offers pharmaceutical products comprising alimentary preparations, amoebocides, analgesics, anthelmintics, anti-aphthous ulcer, anti-erectile dysfunction, anti-gout, anti-hyperkalemia, anti-osteoarthritis, anti-thyroid, anti-ulcerants, antiallergies, antianemics, antiasthma, antibiotics, antidiabetics, antifibrinolytics, antihemorrhoidals, antihistamines, antiosteoporotics, antioxidants, antiparasites, aromatase inhibitors, bone calcium regulators, erythropoiesis stimulating agents, gynae anti-infectives, magnesium, mineral supplements, non-narcotic analgesics, non-hormonals, non-steroidal anti-inflammatory drugs, anti-gout, antibacterials, vitamins, prolactin inhibitors, selective serotonin reuptake inhibitors, steroids, antifungals, antivirals, antiprotozoals, topical ear and nasal preparations, and urological preparations; and generic pharmaceuticals, infusions, lubricants, laxatives, and mouthwash. It also provides pharmaceuticals for cardiovascular, CNS, cough and cold, dialysis, digestive enzymes, eyes, hepatobiliary disorders, hyperphosphatemia, hypoactive sexual desire, inflammatory bowel, oncology, and respiratory tract infections. In addition, the company offers basic chemicals; herbal and nutraceutical; animal health; and crop care products, such as agricultural chemicals, insecticides, and pesticides; and reusable insulin pens under the AnsuPen brand. It exports its products to approximately 42 countries. The company was founded in 1958 and is headquartered in Dhaka, Bangladesh.

Details

Key executives

Contact